adenovirus-interferon gamma based therapy (Guangzhou Doublle Bioproducts/Sun Yat-Sen University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameadenovirus-interferon gamma based therapy (Guangzhou Doublle Bioproducts/Sun Yat-Sen University)
Drug Alias NameE-10B (Guangzhou Doublle Bioproducts/Sun Yat-Sen University)
ClassificationBiologics
Mechanisms of ActionIFN-γ gene transferenceInterferon gamma receptor stimulants
TargetsInterferon gamma receptorInterferon gamma
Therapy Area/IndicationsRespirovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaDiscontinued
Originator CompaniesGuangzhou Dabo Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSun Yat-Sen UniversityGuangzhou Dabo Biological Products Co Ltd
Active IndicationsN/A
Inactive IndicationsRespirovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A